Ameliorative potential of linagliptin and/or calcipotriol on bleomycin-induced lung fibrosis: In vivo and in vitro study
In conclusion, linagliptin/calcipotriol combination may represent an effective therapeutic modality for amelioration of bleomycin-induced pulmonary fibrosis. Graphical abstract
Source: Environmental Toxicology and Pharmacology - Category: Environmental Health Source Type: research
More News: Drugs & Pharmacology | Environmental Health | Klor-Con | Potassium Chloride | Respiratory Medicine | Study | Taclonex | Toxicology